NSIM
SAGE

North Star Investment Management’s Sage Therapeutics SAGE Stock Holding History

North Star Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed -$128 – 1335
2025
Q2 		$128 Hold
14
– – ﹤0.01% 1188
2025
Q1 		$111 Hold
14
– – ﹤0.01% 1174
2024
Q4 		$76 Hold
14
– – ﹤0.01% 1199
2024
Q3 		$101 Hold
14
– – ﹤0.01% 1162
2024
Q2 		$152 Sell
14
-150
-91% -$1.92K ﹤0.01% 1133
2024
Q1 		$3.07K Sell
164
-30
-15% -$692 ﹤0.01% 1044
2023
Q4 		$4.2K Hold
194
– – ﹤0.01% 966
2023
Q3 		$3.99K Hold
194
– – ﹤0.01% 983
2023
Q2 		$9.12K Buy
194
+180
+1,286% +$8.96K ﹤0.01% 867
2023
Q1 		$587 Hold
14
– – ﹤0.01% 1225
2022
Q4 		$534 Hold
14
– – ﹤0.01% 1232
2022
Q3 		$1K Hold
14
– – ﹤0.01% 1098
2022
Q2 		$0 Hold
14
– – ﹤0.01% 1173
2022
Q1 		$0 Hold
14
– – ﹤0.01% 1197
2021
Q4 		$1K Hold
14
– – ﹤0.01% 1148
2021
Q3 		$1K Hold
14
– – ﹤0.01% 1094
2021
Q2 		$1K Hold
14
– – ﹤0.01% 1067
2021
Q1 		$1K Hold
14
– – ﹤0.01% 1028
2020
Q4 		$1K Buy
+14
New +$1.03K ﹤0.01% 1003

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

North Star Investment Management's SAGE Position: Q3 2025 in Review

North Star Investment Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 14 shares — an estimated $128 sold.

North Star Investment Management first reported a position in SAGE in Q4 2020 and held it in 19 quarters. The position peaked at $9.12K in Q2 2023. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • North Star Investment Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • North Star Investment Management sold 14 Sage Therapeutics shares in Q3 2025, an estimated $128.
  • North Star Investment Management first reported a position in Sage Therapeutics in Q4 2020 and held it in 19 quarters.
  • North Star Investment Management's Sage Therapeutics position peaked at $9.12K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on North Star Investment Management's 13F filing for Q3 2025, filed 22 Oct 2025.